ArticleJournal of neurosurgery. Case lessons2025
Olfactory groove meningioma presenting solely with visual impairment: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOlfactory groove meningiomas (OGMs) are rare intracranial tumors that arise from the anterior cranial fossa. Because of their slow-growing and insidious nature, OGMs often go undetected until they reach considerable size, making them among the largest CNS tumors at diagnosis. Common presenting symptoms include headache, anosmia, personality changes, and visual impairment; however, these can be subtle and easily overlooked. OBSERVATIONS: The authors present the case of a female in her 70s who presented with a 5-week history of progressive visual deterioration, initially affecting the right eye. Notably, she exhibited no other common neurological symptoms. Imaging revealed a giant OGM measuring > 6 cm, with mass effect, midline shift, and encasement of both internal carotid arteries. The patient underwent a bifrontal craniotomy and subtotal tumor resection, achieving approximately 80%-90% removal. LESSONS: The patient's visual acuity and field improved over the following weeks. This case underscores the stealthy and potentially dangerous growth of OGMs, particularly when classical symptoms are absent. It highlights the importance of early imaging in unexplained visual loss and the role of a multidisciplinary approach in managing complex skull base tumors. Greater awareness of atypical presentations may aid in earlier diagnosis and improved outcomes. https://thejns.org/doi/10.3171/CASE25657.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.